
Surinder Dang
About Surinder Dang
Data last updated:
Surinder Dang is a Director at Protota Pharmaceuticals Private Limited (since 2018) and Designated Partner at Kaori Consultants Llp (since 2017). The companies operate in Food And Beverages and Business Services. The largest current company by reported revenue is Protota Pharmaceuticals Private Limited at ₹3.37 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Oct 2018 | 2018 | ₹3.37 Cr (FY 2024) | Active | |
| Designated Partner | 22 Jun 2017 | 2017 | Active |
Board colleagues of Surinder Dang
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anmol Surinder Dang | 07806794 | Protota Pharmaceuticals Private Limited , Kaori Consultants Llp | Director |
| Charchit Surinder Dang | 07806804 | Protota Pharmaceuticals Private Limited , Kaori Consultants Llp | Director |
| Meena Surinder Dang | 07807317 | Protota Pharmaceuticals Private Limited , Kaori Consultants Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surinder Dang
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surinder Dang
Surinder Dang currently holds 2 directorships: Protota Pharmaceuticals Private Limited (Director, since 05 Oct 2018, revenue ₹3.37 Cr (FY 2024)); Kaori Consultants Llp (Designated Partner, since 22 Jun 2017).
Surinder Dang was first appointed on 22 Jun 2017 as Designated Partner at Kaori Consultants Llp. The most recent appointment on record is 05 Oct 2018 at Protota Pharmaceuticals Private Limited.
The current boards of Surinder Dang's companies include Anmol Surinder Dang (Protota Pharmaceuticals Private Limited), Charchit Surinder Dang (Protota Pharmaceuticals Private Limited), Meena Surinder Dang (Protota Pharmaceuticals Private Limited).